Skip to main content
Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
2.750
+0.060 (2.23%)
At close: Aug 13, 2025, 4:00 PM
2.750
0.00 (0.00%)
After-hours: Aug 13, 2025, 6:01 PM EDT

MRVI Revenue by Segment
Period Ending Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Nucleic Acid Production
179.08M 196.35M 213.27M 214.55M 209.33M 224.77M 355.23M 478.89M
Nucleic Acid Production Growth
-14.45% -12.65% -39.96% -55.20% -67.84% -72.36% -57.52% -43.28%
Biologics Safety Testing
62.93M 62.99M 63.65M 64.03M 64.77M 64.18M 64.29M 65.03M
Biologics Safety Testing Growth
-2.84% -1.85% -0.99% -1.53% -3.13% -8.23% -8.74% -8.00%
Protein Detection
- - - - - - - - - - - - - - 25.44M 26.24M 23.31M 22.88M

Adjusted EBITDA by Segment
Period Ending Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Biologics Safety Testing
42.59M 43.84M 45.90M 46.22M 47.09M 46.91M 46.52M 48.27M
Biologics Safety Testing Growth
-9.56% -6.54% -1.33% -4.25% -9.54% -14.47% -16.77% -14.56%
Nucleic Acid Production
31.83M 50.81M 70.85M 71.98M 64.87M 82.66M 194.09M 311.31M
Nucleic Acid Production Growth
-50.94% -38.53% -63.50% -76.88% -86.58% -87.05% -70.88% -54.42%

Revenue by Geography
Period Ending Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
North America
122.99M 127.09M 132.08M 131.91M 133.92M 141.06M 174.99M 238.19M
North America Growth
-8.16% -9.90% -24.52% -44.62% -54.30% -58.45% -50.34% -29.64%
APAC
78.80M 89.38M 93.60M 95.30M 89.21M 97.44M 113.10M 99.95M
APAC Growth
-11.67% -8.27% -17.24% -4.65% -24.38% -11.25% 19.34% 5.35%
EMEA
39.57M 42.06M 50.53M 50.69M 50.30M 49.92M 130.78M 204.98M
EMEA Growth
-21.33% -15.76% -61.36% -75.27% -83.56% -88.47% -71.50% -57.84%
Latin and Central America
501.00K 662.00K 706.00K 686.00K 681.00K 527.00K 649.00K 798.00K
Latin and Central America Growth
-26.43% 25.62% 8.78% -14.04% -19.60% -34.78% -5.67% 22.39%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.